Summary
Background Ultraviolet radiation causes cutaneous melanoma. Sunscreen prevents sunburn and protects skin cells against mutations. High-quality epidemiological studies suggest regular sunscreen use prevents melanoma. Objectives To calculate the potential impact fraction (PIF) for melanoma in the U.S.A. and Australia assuming a range of different intervention scenarios intended to increase sunscreen use. Methods We calculated the PIF, the proportional difference between the observed number of melanomas arising under prevailing levels of sunscreen use compared with the number expected under counterfactual scenarios. We used published melanoma incidence projections for Australia and the white population in the U.S.A. from 2012 through to 2031 as the baseline condition, with estimates for protective effects of 'regular sunscreen use' from the literature. Sunscreen prevalence was sourced from national or state surveys. Results Under a plausible public health intervention scenario comprising incremental increases in sunscreen prevalence over a 10-year implementation programme, we estimated that cumulatively to 2031, 231 053 fewer melanomas would arise in the U.S. white population (PIF 11%) and 28 071 fewer melanomas would arise in Australia (PIF 10%). Under the theoretical maximum model of sunscreen use, almost 797 000 (PIF 38%) and approximately 96 000 (PIF 34%) melanomas would be prevented in the U.S.A. and Australia, respectively between 2012 and 2031. A sensitivity analysis using weaker effect estimates resulted in more conservative PIF estimates. Conclusions Overall, interventions to increase use of sunscreen would result in moderate reductions in melanoma incidence, assuming no compensatory overexposure to the sun. Countries with a high incidence of melanoma should monitor levels of sunscreen use in the community.
What's already known about this topic?
• Sunscreen prevents sunburn and protects skin cells (including melanocytes) from mutations induced by ultraviolet radiation.
• Prospective cohort studies and one randomized trial suggest regular sunscreen use reduces risk of melanoma.
• Regular use of sunscreen is uncommon, even in populations residing in areas of high ambient sunlight levels.
What does this study add?
• Under plausible scenarios of increasing prevalence of sunscreen use, cumulative incidence of melanoma between 2012 and 2031 could reduce by~10% in highincidence populations.
• Monitoring sunscreen use in populations is necessary to inform melanoma control efforts.
Ultraviolet (UV) radiation from sunlight is the main environmental cause of cutaneous melanoma, 1, 2 and it has been estimated that between 63% and 90% of cases of melanoma are directly attributable to this exposure. 3, 4 With melanoma incidence still increasing in most susceptible populations globally, 5, 6 there is great potential to reduce this public health burden. Although the mechanisms by which UV radiation causes melanoma have not yet been fully characterized, the consensus of opinion is that wavelengths in the UVB range (290-320 nm) are most likely the main contributors, through pyrimidine dimer and 6-4 photoproduct formation. 7 However, recent experiments have demonstrated the mutagenic effects of wavelengths in the UVA range (320-400 nm), whereby UVA-induced reactive oxygen and nitrogen species combine to excite electrons in melanin pigments. 8 These observations have led to renewed concerns that UVA may contribute more to melanomagenesis than was previously believed. Sunscreens labelled 'broad spectrum' provide protection from both UVB and UVA. 9 Converging lines of evidence provide strong grounds for inferring that sunscreen applied to human skin prior to UV radiation exposure reduces the risk of melanoma: (i) most cutaneous melanomas harbour UV radiation-induced driver mutations in key genes; 7, [10] [11] [12] [13] (ii) under experimental conditions, sunscreens applied to human skin before UV radiation exposure prevent essentially all molecular sequelae of subsequent exposure in epidermal cells, including melanocytes; 14 (iii) sunscreen prevents or retards melanoma development in UV radiation-dependent mouse models; 15 and (iv) in the only randomized trial to test the hypothesis that regular sunscreen use prevents melanoma, participants assigned to 'daily sunscreen' had lower incidence of melanoma than those assigned to 'discretionary use'. 16 However, epidemiological investigations on the association between sunscreen use and melanoma have yielded inconsistent findings. Several systematic reviews have explored the potential cancer preventive properties of sunscreen [17] [18] [19] but all were restricted to observational epidemiological studies, which are prone to several potentially severe biases, including confounding by indication, 20 and for case-control studies, recall bias. Overall, these reviews reported heterogeneous findings from observational studies, with some studies reporting inverse associations between sunscreen use and melanoma, whereas others report positive associations in which people who report regularly using sunscreen have higher risks of melanoma. Although all observational studies face challenges with confounding by indication, prospective studies are less prone to various reporting biases (especially recall bias) than case-control studies. Two population-based prospective studies have examined the association between sunscreen use and melanoma, one reporting no association for ever use [no hazard ratio (HR) reported], 21 and the other reporting a significant protective effect (HR 0Á67, 95% CI 0Á53-0Á83). 22 Only randomized controlled trials, in which people are allocated to treatment groups at random, can adequately assess the association with minimal risk of bias. The only randomized controlled trial examining the effect of regular sunscreen use on skin cancer was conducted in Nambour (Queensland, Australia). That trial found that adults aged 25-75 years randomized to apply daily sunscreen had a borderline significant halving of incident melanomas 16 31 all recommend the use of broad-spectrum sunscreen with a sun protection factor (SPF) of at least 15 (30+ for AAD, CCA, ACS and BAD) as a component of a comprehensive sun protection programme. Adherence to these guidelines, however, remains suboptimal. Given the global consensus in position statements from leading cancer prevention organizations, we sought to estimate the likely impact on melanoma incidence under the assumption that greater numbers of people heeded that advice. We chose two populations for comparison, based upon the availability of recent data on the prevalence of regular sunscreen use, the U.S.A. and Australia.
Patients and methods
The potential impact fraction (PIF) 32 is the proportional difference between the observed number of melanoma cases under prevailing levels of sunscreen use and the number expected under alternative scenarios of higher prevalence of sunscreen use. We used the PREVENT Plus (V. 3Á01, EpiGear International, Sunrise Beach, Queensland, Australia) software package to estimate numbers of potentially preventable melanomas in Australia and the U.S.A. under various scenarios.
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(We also sought relevant data for other populations, including the U.K., but were unable to locate sufficiently representative and recent data for sunscreen prevalence.) The model integrates estimates of the prevalence of sunscreen use at base year, changes in prevalence at subsequent time points under different intervention scenarios, and estimates for the protective effect of sunscreen (expressed as a RR) to generate future estimates of melanoma incidence under the stated scenarios. Specifically, the model compares the projected future incidence of melanoma without interventions (baseline or 'no change' scenario) with the projected future incidence after implementing interventions to increase the prevalence of sunscreen use (see 'Intervention Scenarios'). We assumed that the effect of sunscreen was immediate, and that it took 10 years for melanoma risks among nonusers to decline to those of regular users. This study comprised an ecological analysis of publicly available data; hence no institutional ethical review was required.
Prevalence of sunscreen use and relative risks of melanoma
For the U.S.A., we used sunscreen prevalence data for nonHispanic white adults aged 20-59 years from the National Health and Nutrition Examination Survey (NHANES) 2009-2012 (n = 14 463). 34 In that survey, 6% of men and 22% of women reported 'always' using sunscreen. For U.S. white children we used the 43% prevalence of use 'when going outdoors in summer' estimated from a cross-sectional telephone survey of white youth aged 11-18 years (n = 1390) conducted in 2004. 35 For Australia, we used population-based prevalence estimates for regular sunscreen use in Australian adults aged 16 years and over from the 2010 New South Wales (NSW) Population Health Survey; 36 21% of men and 35% of women reported 'always' applying a broad-spectrum sunscreen (SPF 15+) to exposed skin when in the sun for more than 15 min in summer. These prevalence estimates were applied to adults aged 17 years and over. For Australian children, prevalence estimates were sourced from the NSW School Students Health Behaviours Survey. 37 In 12-to 15-year-olds, prevalence of 'maximum protection sunscreen (SPF 30+)' use when outside for an hour or more between 11Á00 h and 15Á00 h in summer was 39% in boys and 51% in girls; and for 16-to 17-year-olds it was 31% for boys and 48% for girls. The prevalence in 12-to 15-year-olds was applied to 0-to 12-year-olds in our modelling. We used the RR for a protective effect of sunscreen from the long-term follow-up of the Nambour Skin Cancer Prevention Trial (0Á50, 95% CI 0Á24-1Á02). 16 In a sensitivity analysis, we used the HR for use of sunscreen (SPF 15+) on at least one occasion (0Á67, 95% CI 0Á53-0Á87) from the Norwegian Women and Cancer Study. 22 The only other prospective cohort to examine the association between sunscreen use and melanoma, the Nurses' Health Study, did not present an estimate of effect.
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Melanoma incidence data and population projections
We used published melanoma incidence projections for Australia and the white population in the U.S.A. from 2012 to 2031, full methods for which have been published. 6 Briefly, we used cancer registry data on melanoma incidence for the period 1982-2011, and applied modified age-period cohort models to project incidence rates and number of melanomas out to 2031 using Nordpred (https://www.kreftregisteret.no/ en/Research/Projects/Nordpred/Nordpred-software/). 38 
Intervention scenarios
To estimate the incidence reduction from a plausible public health intervention we postulated the scenario in which the prevalence of sunscreen use increased from baseline by 5% per year over a 10-year period (partial uptake, 10-year implementation; model 1). We also modelled the theoretical maximum incidence reduction possible through a sunscreen intervention, in which 100% of the population used sunscreen daily (i.e. all age groups) with immediate implementation from year 1 (2012) of the intervention (theoretical maximum; model 2) ( Table 1) . A 'delayed maximum uptake' scenario assumed 100% sunscreen use for all people but with a 10-year implementation period (full uptake, delayed implementation; model 3). We repeated the 'partial uptake, 10-year implementation' (model 1) scenario for people aged under 75 years only (model 4), and we also examined the effect of the timing of the interventions (school age, working age and preretirement age, models 5-7, respectively), under the assumption that the protective effect of sunscreen is constant across all age groups. The interventions were assumed to have been applied from the year 2012, the first year of our projected incidence rates.
Results
Under a realistic intervention scenario which modelled a 5% per year increase in sunscreen use across the whole population from 2012 to 2022 (partial uptake, 10-year implementation; model 1) ( Fig. 1 ). In the 20-year projection period to 2031, interventions in older adults had a greater impact on melanoma incidence than those targeting school-age children (i.e. when the oldest in the childhood target group would only be reaching their late thirties) ( Table 2 ; Fig. S1 ; see Supporting Information).
We conducted a sensitivity analysis using the more conservative effect estimate from the large population-based Norwegian cohort study. 22 Using this estimate, under the 'partial uptake, 10-year implementation' scenario (model 1) we estimated that cumulatively to 2031, 142 979 fewer melanomas would arise in the U.S. white population (PIF 7%) and 17 520 fewer melanomas would arise in Australia (PIF 6%) (Table S1 ; Fig. S2 ; see Supporting Information). The 'theoretical maximum' scenario (model 2) resulted in estimates of melanoma incidence 24% lower for the U.S. white population and 21% lower for Australia. The interventions in different age groups showed similar trends to our primary analyses using the effect estimate from the Nambour Trial, 16 albeit with lower estimates of prevented melanomas (Table S1 , Fig. S3 ; see Supporting Information).
Discussion
We modelled the potential impact of different scenarios of sunscreen use on future melanoma incidence in two populations with high rates of melanoma, namely the U.S. white population and Australia. Our 'theoretical maximum' impact scenario (full uptake, immediate implementation; model 2) estimated reductions of up to 38% and 34% of melanomas projected cumulatively to the year 2031 in the U.S.A. and Australia, respectively. Some may be surprised that even a universal sunscreen strategy would reduce cumulative melanoma incidence only by one-third. This finding reflects the fact that, even in randomized trial settings, interventions prescribing daily sunscreen use do not confer complete protection because of less-than-perfect adherence and the fact that even high SPF sunscreens do not completely block all UV radiation. As an example, the Nambour sunscreen intervention trial observed that the incidence of melanoma was 50% lower in the intervention group (daily application of sunscreen) than in the control group (discretionary use of sunscreen). The implication is that 50% of melanomas will continue to arise despite 'best practice' sunscreen use. These findings underscore the need for multicomponent interventions targeting multiple sun protection strategies (as reviewed by the U.S. Surgeon General's Call to Action to Prevent Skin Cancer 25 ).
The most effective sunscreen interventions in the short term were those aimed at older adults since the burden of melanoma incidence is highest in these age groups. 6 For example, melanoma rates in 60-79 year olds are expected to be 96 per 100 000 in the U.S. white population by the year 2031 but only 13 per 100 000 in 20-to 39-year-olds. 6 Thus, in the short-to-medium term, sunscreen interventions that target older age groups (i.e. with higher age-specific melanoma rates) would likely yield larger reductions in incidence than interventions targeting younger age groups, assuming that the benefits of sunscreen have an immediate and equal effect in all age groups. For that reason, the school-age intervention led to much more modest reductions in incidence in the time frame that we examined (i.e. through to 2031). We would anticipate increasing benefits of a school-age intervention after longer duration of follow-up, but this would require models extending out beyond 50 years and based on untestable assumptions about the size, age and sex structure and rate of change of the underlying population as well as the possible trajectories of melanoma incidence into the future by age group and birth cohort. 25 Notwithstanding these considerable barriers, we very cautiously examined the possible effects of a school-age intervention, in Australia, with a 70-year follow-up. We assumed that previously reported melanoma incidence trends continue to the year 2031, 6 and then remain stable for the period 2032-2081. We then plotted the 'base-case' scenario assuming no change in the prevalence of sunscreen use and the 'school-age intervention' on the same plot (Fig. 2) . We estimated that by 2081, the school-age intervention would yield a cumulative reduction in melanoma incidence of 20%.
Although these calculations are crude, they demonstrate the extremely long timelines required for school-age interventions to lead to sizeable reductions in total melanoma incidence. This is entirely predictable, since the birth cohorts subject to the intervention take decades to reach older age and develop melanoma at sufficiently high incidence that differences can be detected between those exposed and not exposed to the sunscreen intervention. Given that sun exposure in early life may be particularly important in melanoma development, 39 it remains possible that the benefits of regular sunscreen use may be greater in young people than we have assumed, potentially leading to greater reductions in melanoma incidence than we have estimated here. We are not aware of any published data reporting age-specific effects of sunscreen use on future risk of melanoma; however, we note that the Nambour trial intervened in adults aged 25-75 years and observed a protective effect, indicating that adult-onset sunscreen interventions are beneficial in reducing melanoma incidence. For our calculations of the PIF we used as the highest-level evidence the risk estimate reported by the only randomized controlled trial to examine the effect of regular sunscreen use on melanoma (RR 0Á50). 16 The trial closely monitored sunscreen use, had high levels of adherence, high rates of followup and pathology documentation of all melanoma end points independent of knowledge of sunscreen allocation. The risk estimate from the trial was derived from an 'intention-to-treat' analysis that incorporated the effects of incomplete adherence, dropouts and other factors that attenuate the magnitude of the observed association in practice. However, several limitations of the trial have been noted including the relatively small sample size, low number of melanoma events and the observation that the protective effect was seen for melanomas occurring on both sunscreen intervention and nonintervention body sites. Because of concerns that the effect size from one small Table 1 ) with 70 years of follow-up, represented as the absolute difference in cumulative melanoma incidence between baseline ('no change') and the intervention in the Australian population to 2081.
trial might be extreme, we conducted a sensitivity analysis using the effect estimate from the Norwegian cohort study 22 (n = 143 844; mean follow-up 10Á7 years; n = 543 melanoma events), yielding more conservative impact fractions. This estimate, however, was based on a time-dependent analysis of sunscreen use defined as 'sunscreen SPF ≥ 15 on one or more occasion' compared with the reference group 'consistent use of SPF < 15'.
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A priori, we did not use risk estimates from case-control studies (or meta-analyses of case-control studies) for this analysis because of the dual concerns of confounding by indication and, separately, recall bias, which are intractable for casecontrol studies of melanoma. (Confounding by indication may also affect cohort studies, and if operative, would bias effect estimates towards a positive association between use of sunscreen and melanoma.)
We are aware of only one other study that has evaluated the impact of interventions to limit exposure to UV radiation on melanoma incidence. de Vries et al. 40 modelled the potential of several scenarios intended to prevent melanoma in four European countries (Finland, Malta, the Netherlands and Scotland) using a similar method incorporating age-specific relative risks and prevalence estimates. Their scenarios did not incorporate sunscreen use, but rather increased 'protection' from UV radiation in occupational and recreational settings, a reduction in use of sunbeds and a reduction in childhood sunburns. In general, de Vries et al. reported that interventions aimed at protecting people during outdoor work and outdoor hobbies combined with interventions to prevent sunbed use and sunburns in childhood were the most effective, resulting in PIFs ranging from 14% to 20% cumulatively to the year 2050. Some of the interventions that we modelled are clearly not achievable in practice (for example the 'theoretical maximum' scenario of full uptake of sunscreen with immediate implementation from 2012). We have, however, presented a number of alternative scenarios that describe the full range of effects on future melanoma incidence that might be achieved in theory. Our estimates are based on a number of assumptions including the representativeness of the prevalence estimates, the size of the protective effect, a presumption of constancy of effect across all age groups and the projected incidence rates. In addition, concerns have been expressed that exhorting people to use sunscreen might lead them to increase their exposure to the sun and thereby (paradoxically) increase their risks of melanoma, 41 although evidence suggests this is the case only when sun exposure is intentional, and not when it is unintentional. 42 Our choice of study populations was based on the availability of recent nationally representative data on the prevalence of sunscreen use; such data was unavailable for the U.K. This underscores the need for health authorities to monitor levels of sunscreen use (as well as other sun protection measures) in countries where melanoma is a concern.
In summary, sunscreens, designed to protect human skin against the burning effects of acute sun exposure, also decrease the amount of UV radiation damage to epidermal cells and although randomized trial data is less abundant than we would like, the totality of evidence strongly suggests that people who use sunscreen regularly enjoy some protection from melanoma. 23 Although melanoma incidence is the focus of this report, the impact of future sunscreen would go beyond melanoma reduction, and increase the even more substantial burdens of actinic keratoses and cutaneous squamous cell carcinomas. Assuming no 'compensatory sun exposure' among people using sunscreen, then interventions designed to increase the proportion of people who use sunscreen regularly in the population are likely to result in sizeable reductions in melanoma incidence (as well as other skin tumours) into the future.
